These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30677023)

  • 21. Development of novel LP1-based analogues with enhanced delta opioid receptor profile.
    Pasquinucci L; Turnaturi R; Prezzavento O; Arena E; Aricò G; Georgoussi Z; Parenti R; Cantarella G; Parenti C
    Bioorg Med Chem; 2017 Sep; 25(17):4745-4752. PubMed ID: 28734666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the activation pathway and G
    Mondal D; Kolev V; Warshel A
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26218-26225. PubMed ID: 33020275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist.
    Guarna M; Bartolini A; Ghelardini C; Galeotti N; Bracci L; Stefano GB; Bianchi E
    Brain Res Mol Brain Res; 2003 Nov; 119(1):100-10. PubMed ID: 14597234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling.
    Samoshkin A; Convertino M; Viet CT; Wieskopf JS; Kambur O; Marcovitz J; Patel P; Stone LS; Kalso E; Mogil JS; Schmidt BL; Maixner W; Dokholyan NV; Diatchenko L
    Sci Rep; 2015 Dec; 5():18198. PubMed ID: 26657998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Wang JB; Garzón J
    Cell Signal; 2008 Oct; 20(10):1855-64. PubMed ID: 18652891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay between Two Allosteric Sites and Their Influence on Agonist Binding in Human μ Opioid Receptor.
    Bartuzi D; Kaczor AA; Matosiuk D
    J Chem Inf Model; 2016 Mar; 56(3):563-70. PubMed ID: 26863088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain.
    Páldy E; Bereczki E; Sántha M; Wenger T; Borsodi A; Zimmer A; Benyhe S
    Neurochem Int; 2008 Dec; 53(6-8):309-16. PubMed ID: 18804501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide.
    Yang Y; Li Q; He QH; Han JS; Su L; Wan Y
    Exp Mol Med; 2018 May; 50(5):1-16. PubMed ID: 29780163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of increased NaCl intake on rat brain endogenous μ-opioid receptor signalling.
    Dadam F; Zádor F; Caeiro X; Szűcs E; Erdei AI; Samavati R; Gáspár R; Borsodi A; Vivas L
    J Neuroendocrinol; 2018 Apr; 30(4):e12585. PubMed ID: 29486102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robust age, but limited sex, differences in mu-opioid receptors in the rat brain: relevance for reward and drug-seeking behaviors in juveniles.
    Smith CJW; Ratnaseelan AM; Veenema AH
    Brain Struct Funct; 2018 Jan; 223(1):475-488. PubMed ID: 28871491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing light chain mutation effects on thrombin via molecular dynamics simulations and machine learning.
    Xiao J; Melvin RL; Salsbury FR
    J Biomol Struct Dyn; 2019 Mar; 37(4):982-999. PubMed ID: 29471734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for the mu opioid receptor in the antidepressant effects of buprenorphine.
    Robinson SA; Erickson RL; Browne CA; Lucki I
    Behav Brain Res; 2017 Feb; 319():96-103. PubMed ID: 27818236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular Transfer of Na
    Vickery ON; Carvalheda CA; Zaidi SA; Pisliakov AV; Katritch V; Zachariae U
    Structure; 2018 Jan; 26(1):171-180.e2. PubMed ID: 29249607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation.
    Trafton JA; Abbadie C; Marek K; Basbaum AI
    J Neurosci; 2000 Dec; 20(23):8578-84. PubMed ID: 11102461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral μ-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminals.
    Baillie LD; Schmidhammer H; Mulligan SJ
    Neuropharmacology; 2015 Jun; 93():267-73. PubMed ID: 25721395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.
    Moreno E; Quiroz C; Rea W; Cai NS; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; Ferré S
    J Neurosci; 2017 Feb; 37(5):1176-1186. PubMed ID: 28007761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
    Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
    Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mu Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity.
    Chaturvedi K; Shahrestanifar M; Howells RD
    Brain Res Mol Brain Res; 2000 Mar; 76(1):64-72. PubMed ID: 10719216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.
    Filizola M; Laakkonen L; Loew GH
    Protein Eng; 1999 Nov; 12(11):927-42. PubMed ID: 10585498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition.
    Chen W; Song B; Lao L; Pérez OA; Kim W; Marvizón JC
    Neuropharmacology; 2007 Oct; 53(5):664-76. PubMed ID: 17845806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.